Mutations in KMT2D suggest epigenetic mechanisms may be involved in LMC development whereas it is not very surprising to see TP53, PIK3CA, and PTEN gene mutations since they have roles in multiple pathways in our body and frequently mutated in multiple cancer types. The gene discussed is TP53; the disease is cancer.